Status:
COMPLETED
Clotting Parameters After Medical Abortion
Lead Sponsor:
NHS Lothian
Collaborating Sponsors:
University of Edinburgh
Conditions:
Abortion Early
Abortion, Complete
Eligibility:
FEMALE
16+ years
Brief Summary
Venous thromboembolism (VTE - blood clots that form in deep veins or in the lungs) has been identified as a leading cause of death in economically developed countries for pregnant and recently-pregnan...
Detailed Description
Sample population: Women who attend the abortion service at the Chalmers Centre to receive abortion assessment and abortion care. There will be 3 groups recruited based upon gestational age of pregnan...
Eligibility Criteria
Inclusion
- Group 1:
- Pregnant and seeking abortion
- Gestation of pregnancy less than 10 weeks
- Healthy, no medical conditions
- Group 2:
- Pregnant and seeking abortion
- Gestation of pregnancy between 10 and 14 weeks
- Healthy, no medical conditions
- Group 3:
- Pregnant and seeking abortion
- Gestation of pregnancy between 14 to 20 weeks
- Healthy, no medical conditions
- Group 4:
- Non pregnant
- Healthy, no medical conditions
- Able to speak English independently
Exclusion
- All groups:
- Unable to give informed consent
- Previous or current venous thromboembolism
- Current smoker
- Personal or family history of thrombophilia or haemophilia
- Taking medicines known to affect clotting parameters (e.g. Aspirin)
- Groups 1-3:
- \- Planning to commence hormonal contraception prior to second blood test.
- Group 4:
- \- Using hormonal contraception at baseline visit
Key Trial Info
Start Date :
March 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 12 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04824118
Start Date
March 26 2021
End Date
August 12 2021
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chalmers Centre for Sexual and Reproductive Health
Edinburgh, United Kingdom, EH39ES